Our Company

Patient-inspired Solutions

Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.

Track Record of Innovation

Through our proven scientific, development and manufacturing capabilities, Alkermes is uniquely positioned to be an engine of innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.

The success of our approach is reflected in:

  • Proven expertise reflected in a diversified commercial product portfolio;
  • A pipeline of novel product candidates focused on CNS diseases in clinical development;
  • Proprietary science and technology that leads to the discovery of new, patentable medicines; and
  • Our commitment to developing new treatment options for major diseases with patient needs in mind.

All this, combined with our resources and strong global presence, position us as a leading innovator in the global pharmaceutical market, today and for the future.

Other Resources

Email Alerts

Stay in Touch with Alkermes